{
  "name": "Vertex Pharmaceuticals",
  "slug": "vertex-pharmaceuticals",
  "ticker": "VRTX",
  "fetched_at": "2025-12-06T12:22:01.991546+00:00",
  "news": [
    {
      "title": "Vertex Presents New Data on CASGEVY®, Including First-Ever Data in Children Ages 5-11 Years, at the American Society of Hematology Annual Meeting and Announces Plan for Global Regulatory Submissions - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMijAFBVV95cUxNc28zMDZVUU5CNVJfRkEzcXNZZ2stWUFyUmtyZHlfZU5JdFlYcVB0ZFlaWXhQcmVuR2RFSWZQdGVUMXgtaUNDeXdqendJMW05UFp2YnFfV2lMdVhtYUVOSFhvWFV4M3JrTGpjNHFsTnZxN3Y4bFB0QnFndjZieDlFVTVORFQ2THFZUU5wMQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMijAFBVV95cUxNc28zMDZVUU5CNVJfRkEzcXNZZ2stWUFyUmtyZHlfZU5JdFlYcVB0ZFlaWXhQcmVuR2RFSWZQdGVUMXgtaUNDeXdqendJMW05UFp2YnFfV2lMdVhtYUVOSFhvWFV4M3JrTGpjNHFsTnZxN3Y4bFB0QnFndjZieDlFVTVORFQ2THFZUU5wMQ?oc=5\" target=\"_blank\">Vertex Presents New Data on CASGEVY®, Including First-Ever Data in Children Ages 5-11 Years, at the American Society of Hematology Annual Meeting and Announces Plan for Global Regulatory Submissions</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-12-06T12:01:00+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "1 Reason I'll Never Sell Vertex Pharmaceuticals Stock - The Motley Fool",
      "link": "https://news.google.com/rss/articles/CBMimAFBVV95cUxOV3ROaTdUSmtOWENrTHZPOGhSbGdXa0RKUjk1U0RzWnU0d0g1WU40ODRlaG15WndxTVJpYjVHTlFqUWhHS3BvNFlyZHVqZkxqWnExRlRlMjI2TmEtTUZPeTRSNXNWbkYtVWwxb1BxUzVMdHNnVm9Qb1ZxY0dQd2Fzd053NF92S1ZvZWF6QnBPR3lQV0NtanczNg?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMimAFBVV95cUxOV3ROaTdUSmtOWENrTHZPOGhSbGdXa0RKUjk1U0RzWnU0d0g1WU40ODRlaG15WndxTVJpYjVHTlFqUWhHS3BvNFlyZHVqZkxqWnExRlRlMjI2TmEtTUZPeTRSNXNWbkYtVWwxb1BxUzVMdHNnVm9Qb1ZxY0dQd2Fzd053NF92S1ZvZWF6QnBPR3lQV0NtanczNg?oc=5\" target=\"_blank\">1 Reason I'll Never Sell Vertex Pharmaceuticals Stock</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The Motley Fool</font>",
      "published": "2025-12-04T20:10:00+00:00",
      "source": "The Motley Fool"
    },
    {
      "title": "Vertex Pharmaceuticals Positioned for Blockbuster Success in Rare Disease Market with Strong Renal Franchise and Promising Clinical Data - TipRanks",
      "link": "https://news.google.com/rss/articles/CBMijwJBVV95cUxOclBILUhfV1Qza0Uxcy13RHFvV1ZReV9hdzFtU3Q5ei1VX3VTUFI0ZG1wc1Y1VlE4bVVJQW5Nd1QySGJ5N0xZN21IVkxoXzNETUJfZ0hyS0ZBaGV6c2VXSjYzdExjZ2Q3QjhOZG5qaThYekpqM3JCY1hkNlVFU05Kc2Q0QS02SHZRTVBRLTRULVhuVlQzeXROYlpOQ3dmYzlyUFoyOHBFdkUxZHdycEtPTGlYZFRqQjhMWFdDYnBDWVhLdzYyR0hYUUJSZjFvVlFEM1c0R25PTE52aWFFTUZzMjlOWm9XeWMxVUtKU2VPUVRCeWlOb0xaRVBleGREQVoyUVBaQXV5ZE9MY3cwNm1N?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMijwJBVV95cUxOclBILUhfV1Qza0Uxcy13RHFvV1ZReV9hdzFtU3Q5ei1VX3VTUFI0ZG1wc1Y1VlE4bVVJQW5Nd1QySGJ5N0xZN21IVkxoXzNETUJfZ0hyS0ZBaGV6c2VXSjYzdExjZ2Q3QjhOZG5qaThYekpqM3JCY1hkNlVFU05Kc2Q0QS02SHZRTVBRLTRULVhuVlQzeXROYlpOQ3dmYzlyUFoyOHBFdkUxZHdycEtPTGlYZFRqQjhMWFdDYnBDWVhLdzYyR0hYUUJSZjFvVlFEM1c0R25PTE52aWFFTUZzMjlOWm9XeWMxVUtKU2VPUVRCeWlOb0xaRVBleGREQVoyUVBaQXV5ZE9MY3cwNm1N?oc=5\" target=\"_blank\">Vertex Pharmaceuticals Positioned for Blockbuster Success in Rare Disease Market with Strong Renal Franchise and Promising Clinical Data</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">TipRanks</font>",
      "published": "2025-12-05T14:21:08+00:00",
      "source": "TipRanks"
    },
    {
      "title": "Why Vertex Pharmaceuticals (VRTX) Stock Is Up Today - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMiiwFBVV95cUxOSXhlZWF3d2dOc1pnaDYtSUVSX3ZLMzR2SnN1SnlyWUxRUXdwQW4zNU5tYldCSXBxQ1F0Mlh1ZHp6cm1pX2FMRDhiNUtOSWZxek5uRzlsX3dHV3puclVOSnVQNWVZOFlDTHEzb1pZLXA1UWxVSUxLS1VQV3lNQWhRWGlNd2RERDRqcWlj?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiiwFBVV95cUxOSXhlZWF3d2dOc1pnaDYtSUVSX3ZLMzR2SnN1SnlyWUxRUXdwQW4zNU5tYldCSXBxQ1F0Mlh1ZHp6cm1pX2FMRDhiNUtOSWZxek5uRzlsX3dHV3puclVOSnVQNWVZOFlDTHEzb1pZLXA1UWxVSUxLS1VQV3lNQWhRWGlNd2RERDRqcWlj?oc=5\" target=\"_blank\">Why Vertex Pharmaceuticals (VRTX) Stock Is Up Today</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-12-03T19:11:29+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Vertex upgraded at Morgan Stanley on kidney pipeline - Seeking Alpha",
      "link": "https://news.google.com/rss/articles/CBMilAFBVV95cUxOWTdZcE5YSEp2QW04VVEtTnhfQUh2QV80d2xIVzhfMnpDN3phQmdvZzBFZm5SeFYwZ29IUG9KckVYMjJxc0pqQk9JSWppenFoUDhDaWFGRUs2OEotYUZtV2VhVWdqcHdwNklnMElnX0cxaXRrVUtLZWZ4OVVFNkV6c1JLckM5YnBQTk9nLU5oTy1pOGV3?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMilAFBVV95cUxOWTdZcE5YSEp2QW04VVEtTnhfQUh2QV80d2xIVzhfMnpDN3phQmdvZzBFZm5SeFYwZ29IUG9KckVYMjJxc0pqQk9JSWppenFoUDhDaWFGRUs2OEotYUZtV2VhVWdqcHdwNklnMElnX0cxaXRrVUtLZWZ4OVVFNkV6c1JLckM5YnBQTk9nLU5oTy1pOGV3?oc=5\" target=\"_blank\">Vertex upgraded at Morgan Stanley on kidney pipeline</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Seeking Alpha</font>",
      "published": "2025-12-03T18:47:21+00:00",
      "source": "Seeking Alpha"
    },
    {
      "title": "Vertex Up 9.2% in 3 Months: Should You Buy, Sell or Hold the Stock? - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMic0FVX3lxTE53eUlzM25laWRnNG14Y01rNzJtOGEzVG1ib2tadldiNjdZYzFUcWkzNmRNelo5YnZ6Nk9HWDV2REM0MFYzd1pFSXhnSzhLRkZWWF9RTFFVc1hBZThqby1FVllZSWQwRWk0TmJlU2JpTGRzeVk?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMic0FVX3lxTE53eUlzM25laWRnNG14Y01rNzJtOGEzVG1ib2tadldiNjdZYzFUcWkzNmRNelo5YnZ6Nk9HWDV2REM0MFYzd1pFSXhnSzhLRkZWWF9RTFFVc1hBZThqby1FVllZSWQwRWk0TmJlU2JpTGRzeVk?oc=5\" target=\"_blank\">Vertex Up 9.2% in 3 Months: Should You Buy, Sell or Hold the Stock?</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-12-03T14:01:00+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "2 Brilliant Growth Stocks to Buy Now and Hold for the Long Term - The Motley Fool",
      "link": "https://news.google.com/rss/articles/CBMilwFBVV95cUxQSXdMOWQ0QVV4ZFU4ZHVPOUhJUnpaNVAxRk1TbGxrUDg1aWREems2ekdwV1dKREtPcEtQYnhFRWZzYU1CcE5USWh1MTdCeDNmMFU1MFFQMFhvMmt1dUlPLVpDR1NRYWxyV1hmRF9Ja0pWNFBLZkt0d0x4bnAxU0hSVHYtcUQ1LVh3QTJVM1gtYjM3bVBROFBF?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMilwFBVV95cUxQSXdMOWQ0QVV4ZFU4ZHVPOUhJUnpaNVAxRk1TbGxrUDg1aWREems2ekdwV1dKREtPcEtQYnhFRWZzYU1CcE5USWh1MTdCeDNmMFU1MFFQMFhvMmt1dUlPLVpDR1NRYWxyV1hmRF9Ja0pWNFBLZkt0d0x4bnAxU0hSVHYtcUQ1LVh3QTJVM1gtYjM3bVBROFBF?oc=5\" target=\"_blank\">2 Brilliant Growth Stocks to Buy Now and Hold for the Long Term</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The Motley Fool</font>",
      "published": "2025-12-03T11:15:00+00:00",
      "source": "The Motley Fool"
    },
    {
      "title": "Vertex's gene therapy shows promise in younger children with blood disorders - Reuters",
      "link": "https://news.google.com/rss/articles/CBMi3AFBVV95cUxOWThkMTFHZl8tQWdvbG5ieUpBMHlYdVI1RVhSbmFFNmVTMlBxeWkxQ1VWVkRnR0ZZV2NQYnJIN29oTEU4ck1ubHRJbHpyT0c4UVF1UkV4S0s0UmV2Y183LWJNS2twNHNDY3RYYXBDUGJES0Vwb0s2UHRxSXlDV0ZDcXpXOWJNN0pyc0JudDF2Z0ZIT3RhMHNVOC1pcENwODFBdUozY1lqbzJ2Q0tpZHpfZVpvcTFHa3BfSGZPdHR6bUh3Z2xpSUpFWTgwQXhKcWFJVzdKZlROSExyZUNz?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi3AFBVV95cUxOWThkMTFHZl8tQWdvbG5ieUpBMHlYdVI1RVhSbmFFNmVTMlBxeWkxQ1VWVkRnR0ZZV2NQYnJIN29oTEU4ck1ubHRJbHpyT0c4UVF1UkV4S0s0UmV2Y183LWJNS2twNHNDY3RYYXBDUGJES0Vwb0s2UHRxSXlDV0ZDcXpXOWJNN0pyc0JudDF2Z0ZIT3RhMHNVOC1pcENwODFBdUozY1lqbzJ2Q0tpZHpfZVpvcTFHa3BfSGZPdHR6bUh3Z2xpSUpFWTgwQXhKcWFJVzdKZlROSExyZUNz?oc=5\" target=\"_blank\">Vertex's gene therapy shows promise in younger children with blood disorders</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Reuters</font>",
      "published": "2025-12-06T12:04:29+00:00",
      "source": "Reuters"
    }
  ],
  "product_launches": [
    {
      "title": "Strong Product Launches and Upbeat Guidance Could Be a Game Changer for Vertex Pharmaceuticals (VRTX) - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMijgFBVV95cUxNOFZFNHZzSk1rSnJWVTEwWExLd1FvWVBPUkVkTV9TRG1oUWdTbWgzbWNkdlA3MkVLNmVra3NUUWhBQWFXZ3c5LVNxZFRkWDhkMUZ1QVlUXzg3ZEZwOHY3TTRjMEYxUjlwZFhYVW84QUVXX0lQaTZVbDN4Qk5WM1NQX0EwSVJXZ2piZXl4d3ZB?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMijgFBVV95cUxNOFZFNHZzSk1rSnJWVTEwWExLd1FvWVBPUkVkTV9TRG1oUWdTbWgzbWNkdlA3MkVLNmVra3NUUWhBQWFXZ3c5LVNxZFRkWDhkMUZ1QVlUXzg3ZEZwOHY3TTRjMEYxUjlwZFhYVW84QUVXX0lQaTZVbDN4Qk5WM1NQX0EwSVJXZ2piZXl4d3ZB?oc=5\" target=\"_blank\">Strong Product Launches and Upbeat Guidance Could Be a Game Changer for Vertex Pharmaceuticals (VRTX)</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-08-22T07:00:00+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Vertex’s new pain, blood disorder drugs miss Wall Street expectations - BioPharma Dive",
      "link": "https://news.google.com/rss/articles/CBMimgFBVV95cUxPSzdmS1NOZmlSUk5NZGNNbXdJdi1FajV2ZzVYQU5zaXVxVEV3RnFqNG1MUk9EMEtBT0h1Z1JpOEJsQU1Uek4wRUQtZ1dwc3NxVXlrU2dJbDdNNnplVUxrWkJzMHFreHZqUmFOYktWY2ZLLWtBV2tJZGNvSXFkdGVETXNiNkd1UHR2SFQxTmFIdktQSzFhbzc5a1BR?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMimgFBVV95cUxPSzdmS1NOZmlSUk5NZGNNbXdJdi1FajV2ZzVYQU5zaXVxVEV3RnFqNG1MUk9EMEtBT0h1Z1JpOEJsQU1Uek4wRUQtZ1dwc3NxVXlrU2dJbDdNNnplVUxrWkJzMHFreHZqUmFOYktWY2ZLLWtBV2tJZGNvSXFkdGVETXNiNkd1UHR2SFQxTmFIdktQSzFhbzc5a1BR?oc=5\" target=\"_blank\">Vertex’s new pain, blood disorder drugs miss Wall Street expectations</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">BioPharma Dive</font>",
      "published": "2025-11-04T08:00:00+00:00",
      "source": "BioPharma Dive"
    },
    {
      "title": "Vertex Pharmaceuticals Stock is Down 4% Despite Strong Q3 Results - TIKR.com",
      "link": "https://news.google.com/rss/articles/CBMipAFBVV95cUxNWmctaU5ocDNJQkhYeWU1TE9id3plcjdPcE1jR0NYZ2hFMVp6VXJtbzRSMEVRdGo3Z1VYaElRVzlJQ2JOV2F6OFJORlJudEJQMVhzMDExMUZ4Nnc2dlNIaWhjbVJPa2tCVlZzOGVRcmUyVDhfWi1kM2liNTlINmhlN2lRUHZKSEhXWWdCakVkQ0Vhb2l6SElFdzFfdHFJcF9qUy1KaQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMipAFBVV95cUxNWmctaU5ocDNJQkhYeWU1TE9id3plcjdPcE1jR0NYZ2hFMVp6VXJtbzRSMEVRdGo3Z1VYaElRVzlJQ2JOV2F6OFJORlJudEJQMVhzMDExMUZ4Nnc2dlNIaWhjbVJPa2tCVlZzOGVRcmUyVDhfWi1kM2liNTlINmhlN2lRUHZKSEhXWWdCakVkQ0Vhb2l6SElFdzFfdHFJcF9qUy1KaQ?oc=5\" target=\"_blank\">Vertex Pharmaceuticals Stock is Down 4% Despite Strong Q3 Results</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">TIKR.com</font>",
      "published": "2025-11-04T08:00:00+00:00",
      "source": "TIKR.com"
    },
    {
      "title": "Vertex’s New Products Dim as Analysts Eye Kidney Portfolio - BioSpace",
      "link": "https://news.google.com/rss/articles/CBMilgFBVV95cUxObHk5T3lvemFXaFY4LXUwYkNCRHBBNk1KQ1gwVFZ5Wmw2RW4xTEpWcXFoZ3YtaXJUUWd3c0Z3U0xnSkU3Q0VHUkhqVjh1cTJKME9FY0kzSDRGN2pIaWh5MDlyUVU3OHY0WEFCRHpnaXdEUkFZTWRxeWdvQWU1MVBBZ0FNRXZKLU45RUFQb2F2UmRjTmw2UGc?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMilgFBVV95cUxObHk5T3lvemFXaFY4LXUwYkNCRHBBNk1KQ1gwVFZ5Wmw2RW4xTEpWcXFoZ3YtaXJUUWd3c0Z3U0xnSkU3Q0VHUkhqVjh1cTJKME9FY0kzSDRGN2pIaWh5MDlyUVU3OHY0WEFCRHpnaXdEUkFZTWRxeWdvQWU1MVBBZ0FNRXZKLU45RUFQb2F2UmRjTmw2UGc?oc=5\" target=\"_blank\">Vertex’s New Products Dim as Analysts Eye Kidney Portfolio</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">BioSpace</font>",
      "published": "2025-11-04T08:00:00+00:00",
      "source": "BioSpace"
    },
    {
      "title": "Vertex tops estimates on cystic fibrosis treatment strength, new products - Reuters",
      "link": "https://news.google.com/rss/articles/CBMi2AFBVV95cUxQV1RfcWFhZlB4RnlGTUNfYlJTOEFKaHREZHlEeV9GVHpnaW1zRDliVlMtX3dWdjZkS2RNRWhZaXc0NmdVcW10bVhmQV9NNlh3b3IwckhEME9rTFlIci1hRDF4RlFzRWprOWFTdjlVV1d4dVpIaVFGWXBiWF9tbnJmcFEydUxiNDF1TVJfLTI4QmtvcnIwWVhYd3hNTno2aFhpZF9WNFZjX3lJLVVsNjZfcWZOVTVzU2lXYzV1cmw0bDRpTUFiWjJLUElvRk15d1RKLWJnQy10MmU?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi2AFBVV95cUxQV1RfcWFhZlB4RnlGTUNfYlJTOEFKaHREZHlEeV9GVHpnaW1zRDliVlMtX3dWdjZkS2RNRWhZaXc0NmdVcW10bVhmQV9NNlh3b3IwckhEME9rTFlIci1hRDF4RlFzRWprOWFTdjlVV1d4dVpIaVFGWXBiWF9tbnJmcFEydUxiNDF1TVJfLTI4QmtvcnIwWVhYd3hNTno2aFhpZF9WNFZjX3lJLVVsNjZfcWZOVTVzU2lXYzV1cmw0bDRpTUFiWjJLUElvRk15d1RKLWJnQy10MmU?oc=5\" target=\"_blank\">Vertex tops estimates on cystic fibrosis treatment strength, new products</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Reuters</font>",
      "published": "2025-08-04T07:00:00+00:00",
      "source": "Reuters"
    }
  ],
  "stock": {
    "ticker": "VRTX",
    "currency": "USD",
    "latest": {
      "date": "2025-12-05",
      "close": 455.4800109863281
    },
    "history": [
      {
        "date": "2025-11-26",
        "close": 432.1700134277344
      },
      {
        "date": "2025-11-28",
        "close": 433.6099853515625
      },
      {
        "date": "2025-12-01",
        "close": 425.6000061035156
      },
      {
        "date": "2025-12-02",
        "close": 433.1499938964844
      },
      {
        "date": "2025-12-03",
        "close": 463.1300048828125
      },
      {
        "date": "2025-12-04",
        "close": 457.3599853515625
      },
      {
        "date": "2025-12-05",
        "close": 455.4800109863281
      }
    ],
    "name": "Vertex Pharmaceuticals Incorpor"
  }
}